Hypovolemic shock is treated by replacing lost volume, stopping the source of fluid loss, and supporting blood pressure until the body can recover adequate circulation. The specific approach depends on whether the volume loss comes from bleeding (hemorrhagic) or from other causes like severe burns or dehydration (non-hemorrhagic). Treatment happens in stages, starting with rapid assessment and fluid replacement, then escalating to blood products, medications, or surgery as needed.
What Happens in the Body During Hypovolemic Shock
When the body loses too much blood or fluid, there isn’t enough volume left in the circulatory system to deliver oxygen to organs. Cells switch from their normal oxygen-dependent energy production to an emergency backup mode that generates lactic acid as a byproduct. This is why blood lactate levels serve as a key marker of severity. Lactate above 2 mmol/L is associated with a two- to seven-fold increased risk of death in trauma patients, and levels above 4 mmol/L carry a seven- to 29-fold increase in hospital mortality.
Shock severity is often graded from Class I through Class IV based on the ratio of heart rate to systolic blood pressure (called the shock index). A shock index below 0.6 indicates no significant shock. Values between 0.6 and 1.0 indicate mild shock, 1.0 to 1.4 moderate shock, and anything above 1.4 severe shock. As the class increases, the body progressively loses its ability to compensate: heart rate climbs, blood pressure drops, breathing speeds up, and mental status deteriorates.
First Priority: Replacing Lost Volume
The foundation of treatment is getting fluid back into the bloodstream. For most cases, this starts with intravenous crystalloid solutions. Balanced crystalloids like lactated Ringer’s solution are generally preferred over normal saline (0.9% sodium chloride). A meta-analysis of over 36,000 critically ill patients found that balanced crystalloids were associated with 4% lower mortality and a 2 to 14% reduction in acute kidney injury compared to normal saline. Normal saline in large volumes can cause a condition called hyperchloremic acidosis, where excess chloride ions disrupt the blood’s acid-base balance.
That said, the most important thing in an emergency is speed. Clinicians will use whatever crystalloid is immediately available rather than delay treatment waiting for a specific type.
How Much Fluid and How Fast
The volume and rate of fluid replacement depend on the type of shock. For hemorrhagic shock from trauma, current European guidelines recommend a restrictive fluid strategy. Rather than flooding the system with crystalloids, the goal is to keep systolic blood pressure at 80 to 90 mmHg (or a mean arterial pressure of 50 to 60 mmHg) until the bleeding source is controlled. This approach, called permissive hypotension, prevents dislodging clots that have started to form and avoids diluting the blood’s remaining clotting factors. For penetrating injuries like stab or gunshot wounds, even lower targets of 60 to 70 mmHg systolic may be used.
Permissive hypotension is not used in patients with traumatic brain injury, where the brain needs higher perfusion pressure to avoid further damage.
Blood Products for Hemorrhagic Shock
When shock is caused by significant bleeding, crystalloid fluids alone aren’t enough. The body needs red blood cells to carry oxygen, plasma to maintain clotting factors, and platelets to form clots. Hospitals activate what’s called a massive transfusion protocol when a patient is losing large amounts of blood rapidly.
Current protocols use a balanced ratio of these three components. The recommended ratio ranges from 1:1:1 to 1:1:2 (plasma to platelets to red blood cells). This balanced approach mimics whole blood more closely than older strategies that relied heavily on red blood cells alone. An early balanced approach, sometimes starting with roughly equal units of red cells and plasma plus platelet concentrates, helps prevent the dangerous combination of ongoing bleeding and inability to clot that can spiral out of control.
A medication that helps the body maintain blood clots is also given early in traumatic hemorrhage. The standard dose is 1 gram intravenously over 10 minutes, followed by another gram over the next eight hours. This drug works by blocking the breakdown of clots that have already formed, buying time for surgical teams to locate and stop the bleeding. It is most effective when given within the first three hours after injury.
When Medications Are Used to Support Blood Pressure
Vasopressors, drugs that constrict blood vessels to raise blood pressure, are not the first-line treatment for hypovolemic shock. The core problem is too little volume, not a failure of blood vessel tone. Giving vasopressors before replacing volume can actually worsen organ damage by squeezing already under-supplied blood vessels tighter, further reducing oxygen delivery to tissues like the kidneys, gut, and liver.
However, vasopressors may be used as a temporary bridge in extreme situations. When blood pressure is so low that the brain and heart are at risk of immediate damage, a vasopressor can be started alongside aggressive fluid replacement to maintain just enough perfusion to keep the patient alive while volume is being restored. This is an emergency measure, not a substitute for addressing the underlying volume deficit.
Treatment Differences for Non-Hemorrhagic Causes
Not all hypovolemic shock involves bleeding. Severe dehydration from prolonged vomiting, diarrhea, or heat illness can deplete fluid volume enough to cause shock. In these cases, crystalloid replacement is the primary treatment, and the volumes can be more generous since there’s no active bleeding to worsen.
Burns
Major burns create a unique form of hypovolemic shock. Damaged skin and underlying tissue leak massive amounts of plasma into surrounding tissues, rapidly shrinking circulating volume. Burns covering more than 20% of the body’s surface typically require formal intravenous resuscitation. Smaller burns can often be managed with oral rehydration unless they involve the face, hands, or genitals, or occur in children or elderly patients.
The most widely used approach for burn resuscitation calculates fluid needs based on body weight and the percentage of body surface burned. The standard formula calls for 4 mL of lactated Ringer’s solution per kilogram of body weight per percent of burn area, delivered over the first 24 hours. Half of that volume is given in the first 8 hours, with the remainder over the next 16. For children, the calculation adjusts to 3 mL/kg/% burn. During the second 24 hours, colloid solutions (protein-containing fluids like albumin) are introduced while crystalloids are reduced or stopped. Throughout this process, the team monitors urine output closely, targeting 0.5 to 1 mL per kilogram per hour in adults.
Tracking Whether Treatment Is Working
Replacing volume is only useful if it’s actually restoring oxygen delivery to organs. Several markers help gauge whether resuscitation is on track.
- Urine output is one of the most practical real-time indicators. The target is 0.5 to 1 mL per kilogram of body weight per hour. For a 70 kg adult, that means roughly 35 to 70 mL per hour. Falling below this suggests the kidneys still aren’t getting enough blood flow.
- Lactate levels should trend downward as perfusion improves. Persistently elevated lactate signals that tissues are still oxygen-starved, even if vital signs look better on the surface.
- Base deficit is another blood marker that reflects how acidic the blood has become from poor perfusion. A base deficit worse than negative 6 is associated with significantly worse outcomes in trauma patients.
- Heart rate and blood pressure improve as volume is restored, but these can normalize even when deeper tissue perfusion is still inadequate. This is called occult hypoperfusion, and it’s why relying on vital signs alone can be misleading.
Stopping the Source of Volume Loss
Fluid replacement keeps the patient alive, but definitive treatment means stopping whatever is causing the loss. In hemorrhagic shock, this could mean surgery to repair a damaged organ or blood vessel, interventional radiology procedures to block a bleeding artery, or external pressure and tourniquets for extremity wounds. For non-hemorrhagic causes, it means treating the underlying condition: controlling severe diarrhea, cooling a heat stroke patient, or covering and managing burn wounds to reduce ongoing plasma loss.
The speed of source control is often the single biggest factor in survival. All the fluid and blood products in the world serve as a holding pattern. The clock is running from the moment shock begins, and every minute of inadequate oxygen delivery increases the risk of organ damage that may not be reversible even after volume is restored.